Skip to main content
Figure 3 | Alzheimer's Research & Therapy

Figure 3

From: Calmodulin levels in blood cells as a potential biomarker of Alzheimer’s disease

Figure 3

Influence of age, gender and disease severity on calmodulin levels. (A) Scatter plot of calmodulin (CaM) levels versus age in Alzheimer’s disease (AD) patients and controls. Correlation lines related to control and AD distributions are indicated. (B) Box plot of CaM levels in male (M) and female (F) controls and AD patients. (**p <0.0001, significantly different from both male and female controls). (C) Box plot of CaM levels of control, mild cognitive impairment (MCI) patients and AD patients classified within severity segments, as described in the upper part of Table 1. (**p < 0.0001, significantly different from control).

Back to article page